🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
The purpose of the study was to evaluate the efficacy (how well the medicin...
Status
Completed
Location
Gaborone CRS (Site ID: 12701)
Start Date
2022-09-27
Trial ID
NCT05007821
The purpose of this randomized trial is to verify if leprosy patients, desp...
Status
Completed
Location
Centro de Referência Nacional Alfredo da Matta - FUAM
Start Date
2007-02
Trial ID
NCT00669643
Clofazimine (CFZ) is a promising drug for the treatment of NTM diseases. CF...
Status
Completed
Location
Radboud university medical center
Start Date
2022-02-14
Trial ID
NCT05294146
Treatments Being Tested
The purpose of this study was to compare a 3-month rifapentine (RPT)/clofaz...
Status
Terminated
Location
Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS
Start Date
2021-11-05
Trial ID
NCT04311502
Multidrug-resistant tuberculosis (MDR-TB) is tuberculosis (TB) that is resi...
Status
Active Not Recruiting
Location
TB-HIV Innovations & Clinical Research Foundation Corp
Start Date
2022-06-07
Trial ID
NCT03828201
Treatments Being Tested
Mycobacterium abscessus (MABS) is a group of rapid-growing, multi-drug resi...
Status
Recruiting
Location
St George Hospital
Start Date
2020-03-02
Trial ID
NCT04310930
The goal of this clinical trial is to learn if a new combination antibiotic...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-04
Trial ID
NCT07485010
Treatments Being Tested
The PRESCIENT trial is a Phase IIc, open-label, randomized trial that compa...
Status
Active Not Recruiting
Location
GHESKIO
Start Date
2023-11-24
Trial ID
NCT05556746
endTB-Q Clinical Trial is a Phase III, randomized, controlled, open-label, ...
Status
Completed
Location
Aundh Chest Hospital
Start Date
2020-04-06
Trial ID
NCT03896685